Dearbhaile M. O’Donnell

3.8k citations

48 papers · 1.2k indexed · h-index 18

Oncology top 5%
- Cancer survivorship and care 8
- COVID-19 and healthcare impacts 3
- Cancer Immunotherapy and Biomarkers 3
Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 9
Immunology top 10%
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
Cancer Research
Obstetrics and Gynecology top 10%
Pediatrics, Perinatology and Child Health
- Childhood Cancer Survivors' Quality of Life 4
Surgery
- Intraperitoneal and Appendiceal Malignancies 4

Co-authors: Dermot S. O’Callaghan Finbarr O’Connell Kenneth J. O’Byrne Julie Broderick Juliette Hussey Steve S. Kraman Jonathan Moran Peter J. Selby
Cited by: Oncology Reproductive Medicine Immunology
Journals: Journal of Clinical Oncology (5 papers)The Journal of Immunology (1 paper)The Lancet Oncology (1 paper)
Partner nations: Ireland United Kingdom Australia

In The Last Decade

Dearbhaile M. O’Donnell

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Dearbhaile M. O’Donnell

Since Specialization

Citations

This map shows the geographic impact of Dearbhaile M. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dearbhaile M. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dearbhaile M. O’Donnell more than expected).

Fields of papers citing papers by Dearbhaile M. O’Donnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dearbhaile M. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dearbhaile M. O’Donnell. The network helps show where Dearbhaile M. O’Donnell may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dearbhaile M. O’Donnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dearbhaile M. O’Donnell Line = papers co-authored together Dearbhaile M. O’Donnell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1064O ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer (EOC): Final overall survival (OS) analysis Annals of Oncology ·A. Clamp,Iain A. McNeish,Davide Radice,Rosemary Lord,Agnieszka Michael,Alistair Cook,Radhika Agarwal,Axel Walther,Sarah P. Blagden,Dearbhaile M. O’Donnell,J.D. Brenton,S. Sundar,C. Sessa,L.R. Murphy,Francesco Schiavone,A. Gentry-Maharaj,R.S. Kaplan,M.K. Parmar,JA Ledermann	2025	0
2	The systemic treatment of recurrent ovarian cancer revisited Annals of Oncology ·Thaïs Baert,Annamaria Ferrero,Jalid Sehouli,Dearbhaile M. O’Donnell,Antonio González-Martı́n,Florence Joly,Jacobus van der Velden,Paweł Blecharz,David S.P. Tan,Denis Querleu,Nicoletta Colombo,Andreas du Bois,Jonathan A. Ledermann	2021	96
3	1595P Acceptance of COVID-19 vaccination among cancer patients in an Irish cancer centre Annals of Oncology ·William Mullally,C. Flynn,Pa Carr,Michael J. Kennedy,Dearbhaile M. O’Donnell,Mary McCarthy,Scheryll Alken,Karen A. Cadoo,Sumainizah Sukor,Maeve A. Lowery,Denise Gallagher,Catherine Grant,Fergal C. Kelleher,Sinéad Cuffe	2021	3
4	805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment Annals of Oncology ·Andrew R. Clamp,Elizabeth C James,Iain A. McNeish,Andrew Dean,JW Kim,Dearbhaile M. O’Donnell,Jane Hook,Dolores Gallardo‐Rincón,C. Coyle,Sarah P. Blagden,James D. Brenton,Raj Naik,Timothy Perren,Sudha Sundar,Adrian Cook,Jonathan Badrock,Ann Marie Swart,Mahesh Parmar,Richard Kaplan,Jonathan A. Ledermann	2020	1
5	Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer Obstetrics & Gynecology Science ·Roshni Kalachand,Ciarán Ó’Riain,Sinéad Toomey,Aoife Carr,Kirsten M. Timms,Sharon O’Toole,Stephen F. Madden,Mark Bates,John O’Leary,Noreen Gleeson,Dearbhaile M. O’Donnell,Liam Grogan,Oscar S. Breathnach,Angela M. Farrelly,Britta Stordal,Bryan T. Hennessy	2020	6
6	The use of eHealth to promote physical activity in cancer survivors: a systematic review Supportive Care in Cancer ·Ciarán Haberlin,Tom O’Dwyer,David Mockler,Jonathan Moran,Dearbhaile M. O’Donnell,Julie Broderick	2018	102
7	ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis Annals of Oncology ·A. Clamp,Iain A. McNeish,Andrew Dean,David Gallardo,J. Weon-Kim,Dearbhaile M. O’Donnell,Jane Hook,C. Coyle,Sarah P. Blagden,James D. Brenton,Raj Naik,Timothy Perren,Sudha Sundar,Adrian Cook,Elizabeth C James,Ann Marie Swart,Sally Stenning,Richard Kaplan,Jonathan A. Ledermann	2017	38
8	Do oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland Annals of Oncology ·Catherine M. Kelly,Ronan Feighery,John McCaffrey,M. Higgins,Michelle L. Smith,Séamus O’Reilly,Conleth G. Murphy,Anne M. Horgan,J.M. Walshe,Ray McDermott,Dearbhaile M. O’Donnell,Patrick G. Morris,Maccon Keane,Michael J. Martin,Karen Duffy,Alina Mihai,John Armstrong,Eibhlin Mulroe,Verena Murphy	2017	6
9	Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy Thrombosis Research ·Feras Abu Saadeh,Ream Langhe,D.M. Galvin,Sharon O’Toole,Dearbhaile M. O’Donnell,Noreen Gleeson,Lucy Norris	2016	25
10	Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer QUT ePrints (Queensland University of Technology) ·Dermot S. O’Callaghan,Elton Rexhepaj,Kathy Gately,Linda Coate,David Delaney,Dearbhaile M. O’Donnell,Elaine W. Kay,Finbarr O’Connell,William M. Gallagher,Kenneth J. O’Byrne	2015	3
11	Tumour islet Foxp3⁺T-cell infiltration predicts poor outcome in nonsmall cell lung cancer European Respiratory Journal ·Dermot S. O’Callaghan,Elton Rexhepaj,Kathy Gately,Linda Coate,David Delaney,Dearbhaile M. O’Donnell,Elaine W. Kay,Finbarr O’Connell,William M. Gallagher,Kenneth J. O’Byrne	2015	55
12	Testing the ‘teachable moment’ premise: does physical activity increase in the early survivorship phase? Supportive Care in Cancer ·Julie Broderick,Juliette Hussey,Megan Kennedy,Dearbhaile M. O’Donnell	2013	34
13	The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors—a pilot study Supportive Care in Cancer ·Emer Guinan,Juliette Hussey,Julie Broderick,Fiona E. Lithander,Dearbhaile M. O’Donnell,Michael J. Kennedy,E. Connolly	2013	58
14	The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Dermot S. O’Callaghan,Dearbhaile M. O’Donnell,Finbarr O’Connell,Kenneth J. O’Byrne	2010	234
15	OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions The Journal of Immunology ·Katy S. Hill,Fiona Errington‐Mais,Lynette P. Steele,Alison Merrick,Ruth Morgan,Peter J. Selby,Nikolaos T. Georgopoulos,Dearbhaile M. O’Donnell,Alan Melcher	2008	26
16	Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen Irish Journal of Medical Science (1971 -) ·Moya Cunningham,Ruth Gilmore,Dearbhaile M. O’Donnell,James S. O’Donnell	2008	6
17	Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming Gene Therapy ·Fiona Errington‐Mais,Jane Jones,Alison Merrick,Andrew Bateman,Kevin J. Harrington,Michael J. Gough,Dearbhaile M. O’Donnell,Peter J. Selby,Richard G. Vile,Alan Melcher	2005	43
18	Severe gingival hyperplasia in a child with I‐cell disease International Journal of Paediatric Dentistry ·Whi in Lee,Dearbhaile M. O’Donnell	2003	14
19	HYPOPROTHROMBINAEMIA ASSOCIATED WITH USE OF CEPHAMANDOLE Australian and New Zealand Journal of Surgery ·Dearbhaile M. O’Donnell	1991	5
20	Contraception in the female transplant recipient. Dialysis & Transplantation ·Dearbhaile M. O’Donnell	1986	7

About Dearbhaile M. O’Donnell

Dearbhaile M. O’Donnell is a scholar working on Reproductive Medicine, Transplantation and Oncology, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Cancer survivorship and care (8 papers), Immunotherapy and Immune Responses (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Immune Cell Function and Interaction (4 papers), COVID-19 and healthcare impacts (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Oncology (612 citations), Reproductive Medicine (136 citations) and Immunology (270 citations). Dearbhaile M. O’Donnell has collaborated with scholars based in Ireland, United Kingdom and Australia. Frequent co-authors include Dermot S. O’Callaghan, Finbarr O’Connell, Kenneth J. O’Byrne, Julie Broderick, Juliette Hussey, Steve S. Kraman, Jonathan Moran, Peter J. Selby, Alan Melcher and Tom O’Dwyer. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact